AMSTERDAM, Jan 29 (Reuters) - AstraZeneca's COVID-19
vaccine should provide some protection to people over the age of
55, but it is hard to say how much at this stage, the European
Medicines Agency said on Friday.
"At least some protection is expected in this subgroup,
although the exact level of protection cannot be estimated for
the time being," Bruno Sepodes, vice chair of EMA's human
medicines committee, told a news briefing.
Sepodes added that EMA's recommendation to administer the
shot to people over the age of 18 did not contradict advice from
Germany's vaccine committee, which has said it should be given
to adults up to the age of 64.
(Reporting by Ludwig Burger, Writing by Douglas Busvine;
Editing by Kevin Liffey)
Astrazeneca (AZN)
